Fundz

Strand Therapeutics has raised $153 million in a Series B funding round led by Kinnevik to advance its programmable mRNA therapeutic pipeline.

PRIVATEAug 07, 2025

Amount Raised

$153 Million

Round Type

Series B

CambridgeBiotechnology

Investors

Gradiant CorporationLG Technology VenturesJic VgiPotentumAnriEli Lilly And CompanyPlayground GlobalFPV VenturesRegeneron VenturesIconiqAmgen VenturesAlderline GroupKinnevik

Description

Strand Therapeutics announced $153M Series B funding led by Kinnevik, with participation from new investors and existing backers. The funding will propel the expansion of their mRNA pipeline, including the STX-001 therapy. Recent Phase 1 data for STX-001 showed promising initial results. Strand has now raised over $250M total.

Who to call at STRAND THERAPEUTICS INC, and when

A new round usually means STRAND THERAPEUTICS INC is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day STRAND THERAPEUTICS INC raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at STRAND THERAPEUTICS INC, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

STRAND THERAPEUTICS INC

Location

ONE KENDALL SQUARE

Cambridge, Maryland, United States

About

Strand Therapeutics is a biotechnology company.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment STRAND THERAPEUTICS INC raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for STRAND THERAPEUTICS INC's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

STRAND THERAPEUTICS INC raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.